EN
抗体药类似物
Research Grade Ralpancizumab
All
TD-HV275066_1.jpg
  • CatalogTD-HV275066
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsPF-05335810,RN317,CAS:1407495-04-8
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Ralpancizumab


Catalog No. TD-HV275066
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG2-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9, Proprotein convertase 9, Neural apoptosis-regulated convertase 1, NARC1, PCSK9
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q8NBP7
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names PF-05335810,RN317,CAS:1407495-04-8
Background Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV275066_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Ralpancizumab.